A detailed history of Soleus Capital Management, L.P. transactions in Erasca, Inc. stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 2,162,162 shares of ERAS stock, worth $4.09 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares
2,162,162
Previous 2,162,162 -0.0%
Holding current value
$4.09 Million
Previous $5.1 Million 15.68%
% of portfolio
0.5%
Previous 0.52%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.79 - $2.63 $3.87 Million - $5.69 Million
2,162,162 New
2,162,162 $5.1 Million

Others Institutions Holding ERAS

About Erasca, Inc.


  • Ticker ERAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 122,147,000
  • Market Cap $231M
  • Description
  • Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...
More about ERAS
Track This Portfolio

Track Soleus Capital Management, L.P. Portfolio

Follow Soleus Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Soleus Capital Management, L.P. with notifications on news.